Strong returns and supercharged investor demand drive Europe’s EMQQ past $100m milestone
Brexit Talks – A Road to Nowhere?
British Court Refuses To Release Venezuelan Gold To Maduro
Stock markets rise as 4.8 million Americans back to work! What’s next?
Coronavirus: BBC emerges as the UK's clear favourite information source in new audience survey
The future of periods can now be sustainable and cheap
Coronavirus: it is morally indefensible for a nation to keep life-saving drugs for itself
July Monthly
US government buys most of world’s supply of COVID-19 drug remdesivir
Uncertainty grips markets as traders await key news
Seven ways social distancing will change restaurants
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
Australia Places 300k Under Lockdown As Global Cases Near 10.5 Million: Live Updates
Gold soars to a seven-year high on WHO virus warning
Coronavirus deaths and swelling public sector debt share a data-quality problem
Global Hydroxychloroquine Study To Resume After Positive Trial Results
Will Tesla Match Q1 Deliveries? This Analyst Crunches the Numbers
UK government pledges £1 billion to rebuild schools - here's why they need to be sustainable
Punchdrunk: new venture with Pokemon Go designer offers hope for post-pandemic theatre
Whole-town study reveals more than 40% of COVID-19 infections had no symptoms
Why short-term forecasts can be better than models for predicting how pandemics evolve
Futures Flat On Last Day Of Best Quarter In 22 Years
Medical cannabis ETFs on cusp of mainstream breakthrough
New Flu Virus With "Pandemic Potential" Emerges In China
Coronavirus: the antibody drugs few people have been discussing – until now
Macro Briefing | 30 June 2020
How to minimise risk during recessions and economic crises
US advisors add steroids to COVID-19 drug recommendations
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Exclusive: Survey finds startups drifting away from offices, post COVID-19